The prognosis of pancreatic cancer is still very poor. proliferation, increasing

The prognosis of pancreatic cancer is still very poor. proliferation, increasing cell apoptosis and regulating cell cycle as well. tests proven that the mean quantity and pounds of subcutaneous xenografts in naked rodents extracted from Capan-2 cells transfected with COX-2 siRNA had been considerably reduced. COX-2 siRNA could lessen the development of Capan-2 pancreatic tumor… Continue reading The prognosis of pancreatic cancer is still very poor. proliferation, increasing